Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Jasper Therapeutics Announces New Data Presented On Briquilimab Conditioning In Patients With Fanconi Anemia

Author: Benzinga Newsdesk | March 15, 2024 08:04am

Three additional patients with Fanconi Anemia treated with briquilimab prior to stem cell transplant
All six patients with Fanconi Anemia treated with briquilimab achieved full donor engraftment and full blood count recovery and briquilimab was well tolerated

Posted In: JSPR